Article

Heidelberg moves U.S. headquarters

Heidelberg Engineering is moving its corporate U.S. headquarters to the Carlsbad Research Center in Carlsbad, CA, from Vista, CA, in April, citing ?continued, rapid growth? as the reason.

Vista, CA-Heidelberg Engineering is moving its corporate U.S. headquarters to the Carlsbad Research Center in Carlsbad, CA, from Vista, CA, in April, citing “continued, rapid growth” as the reason. The Carlsbad location includes space for future expansion and access to a highly trained biotech employment pool.

The company also will move its service center to a new facility in Rhode Island later this year. The expansion comes after 4 years of double-digit growth built on the success of its leading product, a spectral-domain optical coherence tomography device (Spectralis SD-OCT).

“We feel fortunate to be experiencing such strong growth during one of the biggest economic downturns in our nation’s history,” said Travis Lindsay, general manager and chief operating officer of Heidelberg Engineering, which has worldwide headquarters in Heidelberg, Germany. “The new facilities reflect our position as the leading innovator of confocal scanning laser technology and will help us continue to provide first-in-class service for our customers.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.